TrialJournal of endocrinological investigation2024

Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.

R Pivonello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.